Literature DB >> 12893436

Estrogenic and antiestrogenic regulation of MMP-2 and MMP-13 mRNA in RUCA-I endometrial tumor cells in vitro and in vivo.

Ludger Tüshaus1, Anne-Christine Hopert, Elisabeth Strunck, Christine Schubert, Winfried Wünsche, Günter Vollmer.   

Abstract

We investigated the influence of estrogenic and antiestrogenic treatment on proteolytic activity--especially on MMP-2 and MMP-13--in the RUCA-I transplantable endometrial tumor model. Morphological studies demonstrate that RUCA-I cells are forming highly differentiated gland-like structures by remodelling and invading the underlying ECM. Estrogens upregulate the mRNA levels of MMP-2 and MMP-13 in the rat uterus. Treatment with the pure antiestrogen ICI 182,780 results in the downregulation of MMP-2 and MMP-13 mRNA. The same regulation for MMP-13 mRNA is found in vitro in RUCA-I cells. In contrast, in the transplantation tumor, the mRNA level of MMP-13 is repressed by estrogens and induced by ICI 182,780. MMP-2 mRNA is not regulated by hormones in the transplantation tumor and in RUCA-I cells. The divergent regulation suggests a varying influence of cell-cell-, cell-extracellular matrix interactions and soluble factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893436     DOI: 10.1016/s0304-3835(03)00275-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts.

Authors:  Wenjun Zong; Leslie A Meyn; Pamela A Moalli
Journal:  Biol Reprod       Date:  2008-11-05       Impact factor: 4.285

2.  Bioinformatic analysis of four miRNAs relevant to metastasis-regulated processes in endometrial carcinoma.

Authors:  Lingping Zhu; Zhiqun Shu; Xiaoming Sun
Journal:  Cancer Manag Res       Date:  2018-08-01       Impact factor: 3.989

3.  Investigation of the effects of estrogen on skeletal gene expression during zebrafish larval head development.

Authors:  Ehsan Pashay Ahi; Benjamin S Walker; Christopher S Lassiter; Zophonías O Jónsson
Journal:  PeerJ       Date:  2016-03-31       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.